Boehringer Ingelheim Pharmaceuticals Inc. et al v. Anobri Pharmaceuticals US, LLC et al
| Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH |
| Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. and Shanghai Anovent Pharmaceutical Co., Ltd. |
| 1:2023cv00715 |
| June 30, 2023 |
| US District Court for the District of Delaware |
| William C Bryson |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 10, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Case Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. Associated Cases: 1:23-cv-00715-WCB, 1:23-cv-00716-WCB (rjb) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:23-cv-00715-GBW, 1:23-cv-00716-GBW (rjb) |
| Filing 6 Summons Issued as to Anobri Pharmaceuticals US, LLC on 6/30/2023; NanChang Anovent Pharmaceutical Co., Ltd. on 6/30/2023; Shaghai Anovent Pharmaceutical Co., Ltd. on 6/30/2023. (Attachments: #1 Summons Issued, #2 Summons Issued)(apk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (apk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,284,474 B2 ;7,896,264 B2 ;7,396,341 B2 ;9,027,967 B2 ;7,837,235 B2 ;8,733,341 B2. (apk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/19/2023. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 11/19/2025. (apk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 1 COMPLAINT filed against Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. ( Filing fee $ 402, receipt number ADEDC-4170243.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. (Attachments: #1 Exhibit A-G, #2 Civil Cover Sheet)(apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
